BioAge Labs, Inc. (BIOA)
NASDAQ
BioAge Labs, Inc. annual/quarterly shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BioAge Labs, Inc. shareholder equity for the quarter ending December 31, 2025 were 272.1M, a 15.81% decrease year-over-year.
- BioAge Labs, Inc. shareholder equity for 2025 were 272.1M, a 15.81% decrease from 2024.
- BioAge Labs, Inc. shareholder equity for 2024 were 323.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BioAge Labs, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $272 |
| 2024 | $323 |
| BioAge Labs, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $272 |
| 2024-12-31 | $323 |
BioAge Labs, Inc. Shareholder Equity — FAQ
BioAge Labs, Inc. (BIOA) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIOA's shareholder equity history?
The chart and table above show BioAge Labs, Inc.'s shareholder equity by year and by quarter, including the growth rate.